Haemair have also recently completed a project supported by a grant of £219,017 awarded by Innovate UK to develop a device to treat the comorbidities of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury (AKI). Haemair lead the project and were supported by Derbyshire partners Automated Technologies Ltd. Acute Kidney injury arises commonly in ARDS patients; recent studies indicate that over 40% of patients suffering Covid-19 induced ARDS also suffer AKI. In other forms of ARDS (afflicting around 30,000 UK patients annually), the proportion is up to 50%. The mortality rate for patients suffering these comorbidities can be as high as 85%. Hence, the new technology has the potential to save thousands of lives.
The project is described more fully under “Project Development”.
November 20, 2020 4:46 pm
